Inventor · disambiguated record
Ivan Snajdr
Also filed as: SNAJDR IVAN · ŠNAJDR IVAN
5 granted patents·5 pending applications·4 citations·filing 2018–2024
68Inventor score
Top patents by PatentIndex Score
10 records- 0187US11767332B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2021·Granted Sep 26, 2023·1 cites·3 claims
- 0286US11186595B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2018·Granted Nov 30, 2021·3 cites·13 claims
- 0381US12227528B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2023·Granted Feb 18, 2025·0 cites·4 claims
- 0481US2025122226A1Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0578US12492160B2Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2024·Granted Dec 9, 2025·0 cites·11 claims
- 0663US2023028516A1Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 0754US2024246902A1Prodrugs of 6-diazo-5-oxo-l-norleucineUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 0851US2023128984A1Bile acid-gcpii inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (ibd)UNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0944US2022184184A1Glucose sensitive insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 1036US12240797B2Method of preparing a DON prodrug from L-glutamic acidDRACEN PHARMACEUTICALS INC·Filed 2020·Granted Mar 4, 2025·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Ivan Snajdr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →